Drug Patents owned by Mylan
1. List of Ermeza drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9345772 | MYLAN | Liquid levothyroxine formulations |
Feb, 2035
(11 years from now) | |
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 29 April, 2022
Treatment: NA
Dosage: SOLUTION;ORAL
2. List of Evoclin drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7374747 | MYLAN | Pharmaceutical foam |
Jan, 2024
(9 months from now) | |
| US7141237 | MYLAN | Pharmaceutical foam |
Feb, 2024
(10 months from now) | |
Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient
Market Authorisation Date: 22 October, 2004
Treatment: Treatment of acne vulgaris
Dosage: AEROSOL, FOAM;TOPICAL
EVOCLIN family patents
8
United States
3
Australia
2
Israel
2
Argentina
2
Japan
2
EA
2
Spain
2
Taiwan, Province of China
2
European Union
1
Brazil
1
Yugoslavia
1
Mexico
1
Canada
1
Norway
1
New Zealand
3. List of Olux E drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8962000 | MYLAN | Microemulsion and sub-micron emulsion process and compositions |
Aug, 2025
(2 years from now) | |
| US8460641 | MYLAN | Microemulsion process and composition |
Nov, 2028
(5 years from now) | |
Drugs and Companies using CLOBETASOL PROPIONATE ingredient
Market Authorisation Date: 12 January, 2007
Treatment: Treatment of corticosteroid-responsive dermatoses
Dosage: AEROSOL, FOAM;TOPICAL
OLUX E family patents
6
United States
2
Canada
2
Australia
2
European Union
1
Israel
1
Hong Kong
1
Russia
1
Brazil
1
Japan
1
Argentina
1
South Africa
1
Spain
1
Korea, Republic of
1
Poland
1
Taiwan, Province of China
1
China
4. List of Vusion drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8147852 | MYLAN | Modified azole compounds as antifungal and antibacterial agents |
Mar, 2028
(5 years from now) | |
Drugs and Companies using MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE ingredient
Market Authorisation Date: 16 February, 2006
Treatment: Use for treatment of diaper dermatitis complicated by candidiasis
Dosage: OINTMENT;TOPICAL
VUSION family patents
5
United States
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic